Morphologic alterations of the fear circuitry: the role of sex hormones and oral contraceptives.
cortical thickness
fear circuitry
gray matter volume
oral contraceptives
sex hormones
structural MRI
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
24
05
2023
accepted:
27
09
2023
medline:
1
12
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
Endogenous sex hormones and oral contraceptives (OCs) have been shown to influence key regions implicated in fear processing. While OC use has been found to impact brain morphology, methodological challenges remain to be addressed, such as avoiding selection bias between OC users and non-users, as well as examining potential lasting effects of OC intake. We investigated the current and lasting effects of OC use, as well as the interplay between the current hormonal milieu and history of hormonal contraception use on structural correlates of the fear circuitry. We also examined the role of endogenous and exogenous sex hormones within this network. We recruited healthy adults aged 23-35 who identified as women currently using ( Compared to men, all three groups of women exhibited a larger GMV of the dorsal anterior cingulate cortex, while only current users showed a thinner ventromedial prefrontal cortex. Irrespective of the menstrual cycle phase, never users exhibited a thicker right anterior insular cortex than past users. While associations with endogenous sex hormones remain unclear, we showed that EE dosage in current users had a greater influence on brain anatomy compared to salivary EE levels and progestin androgenicity, with lower doses being associated with smaller cortical GMVs. Our results highlight a sex difference for the dorsal anterior cingulate cortex GMV (a fear-promoting region), as well as a reduced CT of the ventromedial prefrontal cortex (a fear-inhibiting region) specific to current OC use. Precisely, this finding was driven by lower EE doses. These findings may represent structural vulnerabilities to anxiety and stress-related disorders. We showed little evidence of durable anatomical effects, suggesting that OC intake can (reversibly) affect fear-related brain morphology.
Sections du résumé
Background
UNASSIGNED
Endogenous sex hormones and oral contraceptives (OCs) have been shown to influence key regions implicated in fear processing. While OC use has been found to impact brain morphology, methodological challenges remain to be addressed, such as avoiding selection bias between OC users and non-users, as well as examining potential lasting effects of OC intake.
Objective
UNASSIGNED
We investigated the current and lasting effects of OC use, as well as the interplay between the current hormonal milieu and history of hormonal contraception use on structural correlates of the fear circuitry. We also examined the role of endogenous and exogenous sex hormones within this network.
Methods
UNASSIGNED
We recruited healthy adults aged 23-35 who identified as women currently using (
Results
UNASSIGNED
Compared to men, all three groups of women exhibited a larger GMV of the dorsal anterior cingulate cortex, while only current users showed a thinner ventromedial prefrontal cortex. Irrespective of the menstrual cycle phase, never users exhibited a thicker right anterior insular cortex than past users. While associations with endogenous sex hormones remain unclear, we showed that EE dosage in current users had a greater influence on brain anatomy compared to salivary EE levels and progestin androgenicity, with lower doses being associated with smaller cortical GMVs.
Discussion
UNASSIGNED
Our results highlight a sex difference for the dorsal anterior cingulate cortex GMV (a fear-promoting region), as well as a reduced CT of the ventromedial prefrontal cortex (a fear-inhibiting region) specific to current OC use. Precisely, this finding was driven by lower EE doses. These findings may represent structural vulnerabilities to anxiety and stress-related disorders. We showed little evidence of durable anatomical effects, suggesting that OC intake can (reversibly) affect fear-related brain morphology.
Identifiants
pubmed: 38027091
doi: 10.3389/fendo.2023.1228504
pmc: PMC10661904
doi:
Substances chimiques
Contraceptives, Oral, Combined
0
Ethinyl Estradiol
423D2T571U
Progesterone Congeners
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1228504Informations de copyright
Copyright © 2023 Brouillard, Davignon, Turcotte and Marin.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nature. 2022 Apr;604(7906):525-533
pubmed: 35388223
Physiol Behav. 2010 Jan 12;99(1):8-16
pubmed: 19833145
Eur J Epidemiol. 2019 Mar;34(3):211-219
pubmed: 30840181
Transl Psychiatry. 2014 Aug 05;4:e422
pubmed: 25093600
Hum Brain Mapp. 2019 May;40(7):2143-2152
pubmed: 30663172
Neurology. 2018 Apr 17;90(16):e1404-e1412
pubmed: 29661902
Psychoneuroendocrinology. 2023 Aug;154:106292
pubmed: 37210755
Soc Cogn Affect Neurosci. 2012 Oct;7(7):819-30
pubmed: 21990419
Sensors (Basel). 2023 Jan 05;23(2):
pubmed: 36679404
Neuroimage. 2010 Oct 15;53(1):1-15
pubmed: 20547229
Mol Psychiatry. 2016 Apr;21(4):500-8
pubmed: 26122585
J Anxiety Disord. 2021 Mar;78:102361
pubmed: 33508747
Hum Reprod Update. 2014 Jan-Feb;20(1):76-105
pubmed: 24082040
J Biol Chem. 2011 Apr 15;286(15):12971-82
pubmed: 21321128
Front Neurosci. 2015 Feb 20;9:37
pubmed: 25750611
Neurosci Biobehav Rev. 2021 Jun;125:667-697
pubmed: 33621637
Psychoneuroendocrinology. 2011 Sep;36(8):1239-48
pubmed: 21454017
Magn Reson Med Sci. 2022 Mar 1;21(1):41-57
pubmed: 35185061
Brain Res. 2013 Sep 12;1530:22-31
pubmed: 23892107
Psychoneuroendocrinology. 2018 Apr;90:134-140
pubmed: 29482136
Arch Sex Behav. 2014 Feb;43(2):231-50
pubmed: 23807216
Front Neurosci. 2019 Jun 18;13:592
pubmed: 31275099
Neurosci Biobehav Rev. 2022 Dec;143:104923
pubmed: 36280184
Front Behav Neurosci. 2022 Jan 27;15:777911
pubmed: 35153692
Brain Topogr. 2019 Jan;32(1):111-117
pubmed: 30203260
Sci Rep. 2018 Oct 30;8(1):16042
pubmed: 30375425
Semin Reprod Med. 2016 May;34(3):145-51
pubmed: 26960906
Brain Res. 2015 Jan 30;1596:108-15
pubmed: 25446458
Sci Rep. 2020 Nov 16;10(1):19894
pubmed: 33199738
Front Neuroendocrinol. 2023 Jan;68:101040
pubmed: 36243109
Exp Clin Psychopharmacol. 2008 Apr;16(2):156-64
pubmed: 18489019
Depress Anxiety. 2015 Dec;32(12):900-8
pubmed: 26032588
Front Neuroendocrinol. 2022 Oct;67:101031
pubmed: 35998859
Horm Behav. 2018 Nov;106:122-134
pubmed: 30342884
Hum Brain Mapp. 2013 May;34(5):1187-93
pubmed: 22162177
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18788-18798
pubmed: 32690678
Biol Psychiatry. 2013 Feb 15;73(4):371-8
pubmed: 23158459
Nature. 2022 Mar;603(7902):654-660
pubmed: 35296861
Lancet. 2020 Nov 14;396(10262):1553-1554
pubmed: 33189167
Psychiatry Res Neuroimaging. 2022 Jan;319:111420
pubmed: 34856454
Mol Psychiatry. 2020 Mar;25(3):614-628
pubmed: 31028290
Nat Neurosci. 2017 Feb;20(2):287-296
pubmed: 27991897
Neurosci Biobehav Rev. 2022 Nov;142:104882
pubmed: 36150453
Behav Res Ther. 2020 Jun;129:103615
pubmed: 32334278
Annu Rev Psychol. 2012;63:129-51
pubmed: 22129456
Neuroreport. 2009 Jul 1;20(10):930-5
pubmed: 19562831
Front Neuroendocrinol. 2022 Oct;67:101020
pubmed: 35952797
Lancet Psychiatry. 2017 Jan;4(1):73-82
pubmed: 27856395
J Gerontol B Psychol Sci Soc Sci. 2009 Nov;64 Suppl 1:i94-105
pubmed: 19204073
Brain Struct Funct. 2016 Dec;221(9):4631-4641
pubmed: 26862108
Clin Psychol Rev. 2009 Aug;29(6):496-505
pubmed: 19541399
Neuroimage. 2020 Oct 15;220:117125
pubmed: 32634592
Front Endocrinol (Lausanne). 2022 Sep 20;13:885617
pubmed: 36204097
Sci Rep. 2021 Jul 21;11(1):14910
pubmed: 34290327
J Psychiatr Res. 2019 Dec;119:95-101
pubmed: 31590077
Brain Res. 2017 Jan 1;1654(Pt B):123-144
pubmed: 27590721
PLoS One. 2014 Mar 27;9(3):e93432
pubmed: 24676455
Front Neuroendocrinol. 2022 Oct;67:101036
pubmed: 36126748
Sci Rep. 2019 Jul 29;9(1):11003
pubmed: 31358839
Front Neuroendocrinol. 2022 Oct;67:101030
pubmed: 35995079
Cereb Cortex. 2007 Jul;17(7):1550-60
pubmed: 16945978
Front Neuroendocrinol. 2021 Jan;60:100874
pubmed: 33002517
Psychoneuroendocrinology. 2023 Mar;149:105994
pubmed: 36527751
Arch Womens Ment Health. 2015 Feb;18(1):103-11
pubmed: 25113319
Neuropsychobiology. 2022;81(4):257-264
pubmed: 35158360
Contraception. 2013 Jun;87(6):706-27
pubmed: 23375353
Cereb Cortex. 2018 Aug 1;28(8):2959-2975
pubmed: 29771288
Clin Psychol Rev. 2022 Feb;91:102115
pubmed: 34954460
Neuroendocrinology. 2021;111(3):183-206
pubmed: 32155633
Neuroimage. 2016 Jul 1;134:597-606
pubmed: 27109356
Nat Commun. 2022 Apr 19;13(1):2137
pubmed: 35440664
Int J Psychophysiol. 2017 Nov;121:63-71
pubmed: 28893566
Biol Mood Anxiety Disord. 2012 Feb 07;2:3
pubmed: 22738383
J Child Psychol Psychiatry. 2022 Mar;63(3):333-341
pubmed: 34254301
Dialogues Clin Neurosci. 2016 Dec;18(4):373-383
pubmed: 28179809
Compr Psychoneuroendocrinol. 2021 Mar 29;7:100052
pubmed: 35757062
Horm Behav. 2022 Sep;145:105234
pubmed: 35905507
Neuropsychol Rev. 2022 Jun;32(2):400-418
pubmed: 33893904
Brain Sci. 2020 Mar 25;10(4):
pubmed: 32218215
Neurosci Biobehav Rev. 2019 Aug;103:81-108
pubmed: 31129235
Trends Cogn Sci. 2011 Feb;15(2):85-93
pubmed: 21167765
Mol Psychiatry. 2021 Mar;26(3):917-926
pubmed: 33420480
Neuroimage. 2010 Apr 1;50(2):428-33
pubmed: 19969095
Front Neurosci. 2022 Oct 27;16:898487
pubmed: 36389244
Biol Psychiatry. 2009 Dec 15;66(12):1075-82
pubmed: 19748076
Neurology. 2021 Dec 7;97(23):e2328-e2339
pubmed: 34732544
Essays Biochem. 2021 Dec 17;65(6):913-925
pubmed: 34623401
Sci Rep. 2016 Oct 07;6:32833
pubmed: 27713470
Steroids. 2013 Jun;78(6):614-23
pubmed: 23276632
Neuroimage. 2010 Dec;53(4):1244-55
pubmed: 20600995
Horm Behav. 2015 Aug;74:77-85
pubmed: 25917862
J Neuroendocrinol. 2008 Jul;20(7):893-903
pubmed: 18445128
Brain Sci. 2021 Jan 28;11(2):
pubmed: 33525512
Front Psychiatry. 2022 Mar 16;13:835857
pubmed: 35370813
JAMA Psychiatry. 2020 Jun 1;77(6):618-627
pubmed: 32022832
Hum Brain Mapp. 2014 Dec;35(12):5932-45
pubmed: 25081815
Neuropsychol Rev. 2014 Jun;24(2):77-87
pubmed: 24442602
JAMA Psychiatry. 2020 Jan 1;77(1):52-59
pubmed: 31577333
J Affect Disord. 2002 Aug;70(3):229-40
pubmed: 12128235
Arch Womens Ment Health. 2022 Feb;25(1):71-85
pubmed: 34668073
Behav Brain Res. 2022 Jan 24;417:113593
pubmed: 34560130
Sci Rep. 2017 Oct 26;7(1):14111
pubmed: 29074884
J Steroid Biochem Mol Biol. 2010 Aug;121(3-5):491-5
pubmed: 20470886
Curr Psychiatry Rep. 2022 Dec;24(12):861-869
pubmed: 36399234
Biol Sex Differ. 2022 Oct 28;13(1):62
pubmed: 36307876
Neuropsychopharmacology. 2021 Dec;46(13):2278-2287
pubmed: 34493827
Biol Sex Differ. 2022 Jul 26;13(1):43
pubmed: 35883159
Neuropsychopharmacology. 2016 Jan;41(1):320-34
pubmed: 26294108
Neuroreport. 2014 May 28;25(8):596-600
pubmed: 24614364
Biol Psychol. 2011 Mar;86(3):379-82
pubmed: 21138751
Nat Rev Neurosci. 2009 Jan;10(1):59-70
pubmed: 19096369
Sci Rep. 2021 Oct 22;11(1):20925
pubmed: 34686695
Front Neuroendocrinol. 2021 Jan;60:100878
pubmed: 33098847
Eur J Neurosci. 2003 Dec;18(11):3134-44
pubmed: 14656310
Annu Rev Clin Psychol. 2016;12:1-28
pubmed: 26565122
Hum Brain Mapp. 2020 Jun 15;41(9):2495-2513
pubmed: 32141680
Neurosci Biobehav Rev. 2014 Feb;39:34-50
pubmed: 24374381
Hippocampus. 2008;18(10):985-8
pubmed: 18767068
Health Rep. 2015 Oct;26(10):21-8
pubmed: 26488824
Maturitas. 2008 Sep-Oct;61(1-2):151-7
pubmed: 19434887
Psychophysiology. 2022 Oct;59(10):e14074
pubmed: 35579909
Front Behav Neurosci. 2015 Nov 09;9:298
pubmed: 26617500
Front Psychol. 2020 Oct 27;11:556577
pubmed: 33224053
Eur J Endocrinol. 2015 Aug;173(2):D1-12
pubmed: 25877990
Anal Biochem. 2008 Apr 1;375(1):105-14
pubmed: 18162162
Psychol Sci. 2020 Jul;31(7):792-806
pubmed: 32489141
Front Neuroendocrinol. 2005 Oct-Dec;26(3-4):163-74
pubmed: 16309736
Harv Rev Psychiatry. 2019 Sep/Oct;27(5):303-316
pubmed: 31490186
Am J Obstet Gynecol. 1999 Nov;181(5 Pt 1):1263-9
pubmed: 10561657
Sci Rep. 2016 Aug 09;6:31231
pubmed: 27503843
JAMA Psychiatry. 2016 Nov 01;73(11):1154-1162
pubmed: 27680324
Neurosci Biobehav Rev. 2018 May;88:16-25
pubmed: 29530516
Neuroimage. 2020 Dec;223:117287
pubmed: 32853816
Elife. 2019 Mar 13;8:
pubmed: 30864950
Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 Aug;8(8):780-788
pubmed: 36906444
Brain Struct Funct. 2016 Nov;221(8):3845-3867
pubmed: 26897178
J Womens Health (Larchmt). 2012 Dec;21(12):1259-66
pubmed: 22994984
Eur J Neurosci. 2020 Jul;52(1):2466-2486
pubmed: 31631413
JAMA. 2018 May 15;319(19):2009-2020
pubmed: 29800213
Brain Res. 2017 Jan 1;1654(Pt B):87-94
pubmed: 27060769
PLoS One. 2021 Apr 21;16(4):e0249482
pubmed: 33882080
J Comp Neurol. 1993 Oct 8;336(2):293-306
pubmed: 8245220
Psychoneuroendocrinology. 2003 Aug;28(6):751-66
pubmed: 12812862
Horm Behav. 2018 Jan;97:67-74
pubmed: 29079442
Horm Behav. 2018 Apr;100:29-38
pubmed: 29522764
Behav Res Ther. 2016 Nov;86:87-94
pubmed: 27590839
Front Neuroendocrinol. 2022 Oct;67:101035
pubmed: 36075276
Appl Environ Microbiol. 2018 Oct 1;84(20):
pubmed: 30120116
Front Psychol. 2021 May 20;12:641250
pubmed: 34093322
Front Neuroinform. 2014 May 21;8:54
pubmed: 24904400
Hum Brain Mapp. 2010 Jun;31(6):926-33
pubmed: 20496383
Magn Reson Imaging. 2009 Oct;27(8):1163-74
pubmed: 19249168
Neuropsychopharmacology. 2010 Jan;35(1):169-91
pubmed: 19625997
Front Neuroendocrinol. 2022 Oct;67:101037
pubmed: 36154817
Biol Psychiatry. 2012 Jul 1;72(1):19-24
pubmed: 22502987
J Med Internet Res. 2020 Jun 24;22(6):e17109
pubmed: 32442161
Dev Rev. 2008;28(1):62-77
pubmed: 18688292
BMC Psychiatry. 2015 Nov 18;15:295
pubmed: 26581193
Biol Psychiatry. 2011 Nov 15;70(10):920-7
pubmed: 21762880
Biochem Pharmacol. 2006 May 14;71(10):1459-69
pubmed: 16554039
J Clin Neurophysiol. 2017 Jul;34(4):300-306
pubmed: 28644199
J Neuroendocrinol. 2020 Jan;32(1):e12800
pubmed: 31595559
Gynecol Endocrinol. 2022 Mar;38(3):193-201
pubmed: 34913798
Nat Commun. 2018 Jul 3;9(1):2433
pubmed: 29970895
Neuroscience. 2011 Sep 15;191:38-45
pubmed: 21540080
Menopause. 2008 Mar-Apr;15(2):332-9
pubmed: 17667152
J Affect Disord. 2015 Dec 1;188:127-33
pubmed: 26363612
Scand J Public Health. 2015 Mar;43(2):176-82
pubmed: 25504654
J Child Psychol Psychiatry. 2020 Feb;61(2):148-156
pubmed: 31461541
Nat Commun. 2018 Mar 23;9(1):1220
pubmed: 29572476
J Neurosci. 2014 Mar 12;34(11):4043-53
pubmed: 24623781
Neuropsychiatr Dis Treat. 2013;9:449-61
pubmed: 23579318
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Jun 30;34(5):756-65
pubmed: 19782715
Hum Brain Mapp. 2015 Jul;36(7):2644-54
pubmed: 25832993
Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10706-11
pubmed: 16024728
Neurosci Biobehav Rev. 2022 Dec;143:104962
pubmed: 36402227
Neuroimage. 2015 Sep;118:154-62
pubmed: 26057590
J Psychiatr Res. 2011 Aug;45(8):1027-35
pubmed: 21439576
Psychoneuroendocrinology. 2019 Jan;99:251-256
pubmed: 30390443
J Clin Endocrinol Metab. 2000 Oct;85(10):3840-6
pubmed: 11061547
Front Behav Neurosci. 2022 Mar 14;16:775796
pubmed: 35368304
Clin Chem. 1990 Oct;36(10):1769-73
pubmed: 2208652
Contraception. 2012 Nov;86(5):518-25
pubmed: 22673038
Brain Struct Funct. 2017 May;222(4):2001-2015
pubmed: 27709299
Brain Res. 2006 Dec 18;1126(1):176-82
pubmed: 16934233
Nat Methods. 2023 Jan;20(1):34
pubmed: 36635546
Eur J Endocrinol. 2003 Feb;148(2):227-32
pubmed: 12590642
Brain Struct Funct. 2016 May;221(4):1927-37
pubmed: 25716297
Cereb Cortex. 2009 Feb;19(2):464-73
pubmed: 18550597
Neuropsychopharmacology. 2010 Jan;35(1):136-46
pubmed: 19710632
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16988-93
pubmed: 20841422
PLoS One. 2019 May 2;14(5):e0216152
pubmed: 31048888
Contraception. 2009 Aug;80(2):163-9
pubmed: 19631792